128 related articles for article (PubMed ID: 21453742)
1. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
3. [DARPP-32 in the patients with endogenous psychosis].
Ishikawa M; Mizukami K
Brain Nerve; 2007 Nov; 59(11):1257-63. PubMed ID: 18044203
[TBL] [Abstract][Full Text] [Related]
4. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.
Kunii Y; Ikemoto K; Wada A; Yang Q; Kusakabe T; Suzuki T; Niwa S
Med Mol Morphol; 2011 Dec; 44(4):190-9. PubMed ID: 22179181
[TBL] [Abstract][Full Text] [Related]
5. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
[TBL] [Abstract][Full Text] [Related]
6. Profiles of DARPP-32 in the insular cortex with schizophrenia: a postmortem brain study.
Nishiura K; Kunii Y; Wada A; Matsumoto J; Yang Q; Ikemoto K; Niwa S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1901-7. PubMed ID: 21821092
[TBL] [Abstract][Full Text] [Related]
7. Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.
Deng C; Huang XF
J Neurosci Res; 2005 Sep; 81(6):883-90. PubMed ID: 16041805
[TBL] [Abstract][Full Text] [Related]
8. DARPP-32, a phosphoprotein enriched in dopaminoceptive neurons bearing dopamine D1 receptors: distribution in the cerebral cortex of the newborn and adult rhesus monkey.
Berger B; Febvret A; Greengard P; Goldman-Rakic PS
J Comp Neurol; 1990 Sep; 299(3):327-48. PubMed ID: 2229482
[TBL] [Abstract][Full Text] [Related]
9. Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia--a postmortem study.
Kang K; Huang XF; Wang Q; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):867-71. PubMed ID: 19389456
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
11. Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia.
Eastwood SL; Kerwin RW; Harrison PJ
Biol Psychiatry; 1997 Mar; 41(6):636-43. PubMed ID: 9066986
[TBL] [Abstract][Full Text] [Related]
12. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
Kunii Y; Miura I; Matsumoto J; Hino M; Wada A; Niwa S; Nawa H; Sakai M; Someya T; Takahashi H; Kakita A; Yabe H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():123-8. PubMed ID: 24704945
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
Baracskay KL; Haroutunian V; Meador-Woodruff JH
Synapse; 2006 Sep; 60(4):271-9. PubMed ID: 16786528
[TBL] [Abstract][Full Text] [Related]
14. Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.
Guan Q; Zhan Q; He Y; Tan L
Neurosci Lett; 2007 Oct; 426(1):64-8. PubMed ID: 17884291
[TBL] [Abstract][Full Text] [Related]
15. An association study between PPP1R1B gene and schizophrenia in the Chinese population.
Hu JX; Yu L; Shi YY; Zhao XZ; Meng JW; He G; Xu YF; Feng GY; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1303-6. PubMed ID: 17618027
[TBL] [Abstract][Full Text] [Related]
16. Increased ratio of calcineurin immunoreactive neurons in the caudate nucleus of patients with schizophrenia.
Wada A; Kunii Y; Ikemoto K; Yang Q; Hino M; Matsumoto J; Niwa S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):8-14. PubMed ID: 22285318
[TBL] [Abstract][Full Text] [Related]
17. Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain.
Rajput PS; Kharmate G; Somvanshi RK; Kumar U
Neurosci Res; 2009 Sep; 65(1):53-63. PubMed ID: 19465068
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain.
Ouimet CC; LaMantia AS; Goldman-Rakic P; Rakic P; Greengard P
J Comp Neurol; 1992 Sep; 323(2):209-18. PubMed ID: 1328330
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
[TBL] [Abstract][Full Text] [Related]
20. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
